Page 3 - Best Hodgkin's lymphoma doctors: TOP 75 doctors

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg is an oncohematologist specializing in blood cancers at Assuta Medical Center.

• Focuses exclusively on treating blood disorders and cancers
• Expert in the latest treatments for conditions like Hodgkin's lymphoma
• Provides personalized treatment plans for complex blood diseases

Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.

• Expert in treating blood cancers, including Hodgkin's lymphoma
• Focuses on advanced transplant techniques
• Works at one of Israel's leading medical centers

Specializing in radiotherapy and oncology, Dr. Karen Drumea offers expert care at Rambam Medical Center.

• Focuses on personalized treatment plans for Hodgkin's lymphoma
• Extensive experience in radiotherapy techniques
• Affiliated with Rambam Medical Center – a leading healthcare institution

Specialist in hematology with a focus on lymphomas, including Hodgkin's lymphoma, at Rambam Medical Center.

• Expertise in treating Hodgkin's lymphoma cases
• Specialized in hematology with a focus on lymphoproliferative diseases
• Associated with Rambam Medical Center, a leading hospital in Israel

Professor Bosch leads groundbreaking research in Hodgkin's lymphoma, with over 80 clinical trials advancing new treatments. His work at Hospital Quiron Barcelona pushes the boundaries of hematological care.

• Specializes in lymphomas and chronic lymphocytic leukemia
• Published 100+ articles in top journals like The New England Journal of Medicine
• Head of Hematology at IOB Institute of Oncology
• Conducted post-doctoral research at Columbia University

Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology and led the Hematology Department at Emsey Hospital.

• Specializes in stem cell transplantation and acute leukemia
• PhD from Japan Mie Medical School with molecular hematology training
• Head of Hematology Department with extensive international research
• Professor at Ege University and Karadeniz Technical University

Specializes in Hodgkin's lymphoma with extensive academic and clinical experience. Currently practices at Liv Hospital Ulus.

• Board-certified hematologist with 36 years of experience of experience
• Published 32 articles in international peer-reviewed journals
• Member of Turkish Society of Hematology
• Served as Responsible Authority at Istanbul Training and Research Hospital

Dr. Apak specializes in pediatric hematology and oncology, with extensive experience in Hodgkin's lymphoma treatment at Biruni University Hospital.

• Over 26 years of experience of experience in pediatric oncology
• Expert in bone marrow transplantation and CAR T-cell therapy
• Published 75 international papers on pediatric hematology and oncology
• Head of Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa
• Academic Board Member at Istanbul University Department of Pediatrics

Prof. Dr. Rafet Eren is an Associate Professor in Hematology with over 50 publications in national and international journals.

• Specialized in Hematology at Istanbul Training and Research Hospital
• Member of European Society of Hematology and Turkish Hematology Association
• Recipient of Young Researcher Award at 42nd National Hematology Congress
• Fluent in English for international consultations

Prof. Baytan specializes in childhood cancers, with a focus on leukemia and lymphoma at Emsey Hospital.

• 34 years of experience in pediatric hematology and oncology
• Published 15 articles in international refereed journals
• Expert in anemia and vitamin deficiency treatments
• Authored 3 books/book chapters on pediatric hematology

Associate Professor Kaya specializes in hematology and stem cell transplants, with extensive training at top Turkish hospitals.

• Hematology subspecialist with over 20 years of experience of focused experience
• Multiple award-winning researcher in hematologic oncology
• Skilled in stem cell transplantation at VM Medical Park Pendik
• Member of five leading hematology professional societies